4[1]Yoshida H,Shiratori Y,Moriyama M,Arakawa Y,Ide T,Sata M,Inoue O,Yano M,Tanaka M,Fujiyama S,Nishiguchi S,Kuroki T,Imazeki F,Yokosuka O,Kinoyama S,Yamada G,Omata M.Interferon therapy reduces the risk for hepatocellular carcinoma:national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan.IHIT Study Group.Inhibition of Hepatocarcinogenesis by Interferon Therapy.Ann Intern Med 1999; 131:174-181
5[2]Camma C,Giunta M,Andreone P,Craxi A.Interferon and prevention of hepatocellular carcinoma in viral cirrhosis:an evidence-based approach.J Hepatol 2001; 34:593-602
6[3]Shiratori Y,Ito Y,Yokosuka O,Imazeki F,Nakata R,Tanaka N,Arakawa Y,Hashimoto E,Hirota K,Yoshida H,Ohashi Y,Omata M.Antiviral therapy for cirrhotic hepatitis C:association with reduced hepatocellular carcinoma development and improved survival.Ann Intern Med 2005; 142:105-114
7[4]Hirashima N,Mizokami M,Orito E,Koide T,Itazu I,Kumada K,Sakakibara K,Kano H,Lau JY.Case report:development of hepatocellular carcinoma in a patient with chronic hepatitis C infection after a complete and sustained response tointerferon-alpha.J Gastroenterol Hepatol 1996; 11:955-958
8[5]Tamori A,Kuroki T,Nishiguchi S,Morimoto H,Morimoto M,Hirohashi K,Kinoshita AH,Kobayashi K.Case of small hepatocellular carcinoma in the caudate lobe detected after interferon caused disappearance of hepatitis C virus.Hepatogastroenterology 1996; 43:1079-1083
9[6]Kasahara A,Hayashi N,Mochizuki K,Takayanagi M,Yoshioka K,Kakumu S,Iijima A,Urushihara A,Kiyosawa K,Okuda M,Hino K,Okita K.Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C.Osaka Liver Disease Study Group.Hepatology 1998;27:1394-1402
10[7]Miyano S,Togashi H,Shinzawa H,Sugahara K,Matsuo T,Takeda Y,Saito K,Saito T,Ishiyama S,Kaneko M,Takahashi T.Case report:Occurrence of hepatocellular carcinoma 4.5 years after successful treatment with virus clearance for chronic hepatitis C.J Gastroenterol Hepatol 1999; 14:928-930
